Mesenchymal Cell News 10.50 December 18, 2018 | |
| |
TOP STORYPressure-Induced Mesenchymal Stem Cell Osteogenesis Is Dependent on Intermediate Filament Remodeling Scientists demonstrated that cyclic hydrostatic pressure is a potent mediator of cytoskeletal reorganization and increases in osteogenic responses in MSCs. They demonstrated that the intermediate filament (IF) network undergoes breakdown and reorganization with centripetal translocation of IF bundles toward the perinuclear region. [FASEB J] Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)IN VITROF-Doped TiO2 Microporous Coating on Titanium with Enhanced Antibacterial and Osteogenic Activities Both the in vitro and in vivo results indicated that titanium (Ti) O2/calcium-phosphate coatings (TiCP) and TiCP-fluorine (F)1 were of much higher osteogenic activity compared with Ti but lacking of bacterial resistance, whereas TiCP with high F addition exhibited both dramatically improved bacterial resistance and osteogenesis. [Sci Rep] Full Article Isolation and Characterization of Turkey Bone Marrow-Derived Mesenchymal Stem Cells The multipotency of turkey bone marrow-derived mesenchymal stem cells was determined by differentiating cells into osteogenic, adipogenic, chondrogenic and tenogenic lineages. There was upregulated gene expression of tenogenic markers, including mohawk, tenomodulin and EGR1 as well as increased collagen synthesis in BMP12 induced cells. [J Orthop Res] Abstract Amiloride strongly synergized with doxorubicin in combination treatment and exhibited additive or antagonistic effects with carboplatin in canine osteosarcoma cells. [J Vet Intern Med] Full Article IN VIVOUsing the gonadectomy (GNX) model, investigators confirmed that the osteoporotic phenotypes were substantially consistent between female and male mice. Systemic MSC transplantation not only rescued trabecular bone loss in GNX mice but also restored cortical bone mass and bone quality. No differences were detected between the genders. [Exp Mol Med] Full Article This study compared the efficacy of three different doses of mesenchymal stem cells administered by intraperitoneal injection as a therapeutic strategy for compressive SCI. Researchers used adult female C57BL/6 mice that underwent laminectomy at the T9 level, followed by spinal-cord compression for 1 minute with a 30 g vascular clip. [Neuroscience] Abstract Scientists explored shuangxinfang’s (Psycho-cardiology Formula, PCF) psycho-cardiology effects in rats with acute myocardial infarction and explored its potential mechanism. Results showed PCF inhibited inflammation caused by injured myocardium, improved heart function and depression developed from myocardial infarction, and these might partly attribute to the higher bone marrow mesenchymal stem cells mobilization efficiency promoted by PCF. [Biomed Pharmacother] Full Article With the aid of three-dimensional bioprinted sacrificial molds, hydroxybutyl chitosan/oxidized chondroitin sulfate (HBC/OCS) hydrogel with various structures were obtained. After the material constituent optimization process, an injectable hydrogel with a uniform porous structure of 100 μm average pore size was developed to form macroporous hydrogel. In vitro and in vivo biocompatibility of optimized HBC/OCS hydrogel were also assessed. [Biomed Mater] Abstract Modification of the Bone Marrow MSC Population in a Xenograft Model of Early Multiple Myeloma Researchers evaluated the modification of the MSC population in the bone niche in an in vivo model of multiple myeloma (MM). They showed that before an observable engraftment of MM in the bone niche, the proportion of MSC population was significantly decreased, while a significant increase in adipocyte related genes such as PPARγ and CEBPα expression appeared, with no difference in osteogenic differentiation. [Biochem Biophys Res Commun] Abstract Subscribe to one of our other 19 science newsletters such as ESC & iPSC News & Cell Therapy News. | |
| |
REVIEWSMesenchymal Stem Cell-Based Drug Delivery Strategy: From Cells to Biomimetic The authors provide a comprehensive overview of the utility of mesenchymal stem cells (MSCs) in drug and gene delivery as well as MSC membrane coated nanoparticles for therapy and drug delivery, aiming to figure out the significant room for development and highlight the potential future directions. [J Control Release] Abstract | Graphical Abstract Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field. | |
| |
INDUSTRY NEWSCynata Therapeutics Limited announced that the Australian National Health and Medical Research Council has approved a grant to fund a Phase II clinical trial to evaluate Cynata’s Cymerus™ mesenchymal stem cells as a treatment for osteoarthritis. [Cynata Therapeutics (GlobeNewswire, Inc.)] Press Release Prellis Biologics has launched the first ever line of pre-vascularized 3D tissue scaffolds. The scaffolds are biocompatible and can be used by researchers to grow any cell type in 3D formats 1000x larger than 3D spheroids. [Prellis Biologics (Business Wire, Inc.)] Press Release | |
| |
POLICY NEWSTenured Biology Professor Sacked for Research Misconduct The University of Illinois at Urbana-Champaign has fired former tenured biology professor, Fei Wang, after an investigation revealed he had falsified data on grant applications, The News-Gazette, reports. At a meeting on Friday (December 14), the university’s board of trustees made the final decision, effective immediately, to fire Wang. [The Scientist] Editorial What a Partial US-Government Shutdown Would Mean for Science The clock is ticking for US lawmakers, who have fewer than four days — as of 18 December — to pass a new budget for many government agencies, or they will trigger a partial government shutdown. Nature explains why politicians are struggling to reach a deal, what is at stake for science and whether a crisis can be avoided. [Nature News] Editorial
| |
EVENTSNEW 11th World Biomaterials Congress Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Assistant Professor – Cancer Biology (University of Pennsylvania Perelman School of Medicine) Assistant Professor Positions – Department of Cardiology (Boston Children’s Hospital) Assistant Professor – Department of Biological Sciences (Rutgers University Newark) Tenure Track Assistant Professor – Center for Regenerative Medicine (Massachusetts General Hospital) Postdoctoral Position – Regenerative Medicine, Stem Cells & Bioengineering (Igenomix Foundation) Associate Professor/Professor – Regenerative Medicine or Stem Cell Biology (University of Toronto) Postdoctoral Researcher – Tissue Engineering & Organs on a Chip (OHSU School of Dentistry) Postdoctoral Fellowships – Nanomedicine & Biomedical Engineering (University of British Columbia) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|